United States securities and exchange commission logo January 19, 2021 Laure-H l ne Mercier Chief Financial Officer Innate Pharma S.A. 117 Avenue de Luminy--BP 30191 13009 Marseille, France Re: Innate Pharma SA Registration Statement on Form F-3 Filed January 13, 2021 File No. 333-252074 Dear Ms. Mercier: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Abby Adams at (202) 551-6902 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey Cohen, Esq.